Moleculent (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 11, 2024
- Vertical
- Biotech
- Funding URL
- View Funding Page
- Funding Amount:
- $26,000,000
Company Info
- Founders
- Olle Ericsson
- Company Description
- Moleculent, headquartered in Stockholm, is focused on advancing its functional biology platform, which enables the mapping of cell-cell communication directly in clinical tissue. By detecting and profiling cell-to-cell interactions within their tissue environment, Moleculent aims to enhance the understanding of cell communication networks, disease pathways, and drug responses.
- Market
- Healthcare
- Location
- Stockholm, Sweden
- Coinvestors
- Arch Venture Partners, Eir Ventures